二甲双胍
医学
磺酰脲
血糖性
胰岛素抵抗
糖尿病
胰岛素
药品
内科学
内分泌学
药理学
作者
Clifford J. Bailey,Robert C. Turner
标识
DOI:10.1056/nejm199602293340906
摘要
Metformin (dimethylbiguanide) is an orally administered drug used to lower blood glucose concentrations in patients with non-insulin-dependent diabetes mellitus (NIDDM).1 It improves insulin sensitivity and thus decreases the insulin resistance that is prevalent in NIDDM. The efficacy of glycemic control achieved with metformin is similar to that achieved with sulfonylureas, although their modes of action differ. Metformin can be used either as initial therapy or as an additional drug when sulfonylurea therapy alone is inadequate. In this article we shall discuss the pharmacology and clinical use of metformin, which is now available in the United States.The Burden of Non-Insulin-Dependent . . .
科研通智能强力驱动
Strongly Powered by AbleSci AI